194 related articles for article (PubMed ID: 38338806)
1. Development of Novel Bioluminescent Biosensors Monitoring the Conformation and Activity of the Merlin Tumour Suppressor.
Pipchuk A; Kelly T; Carew M; Nicol C; Yang X
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338806
[TBL] [Abstract][Full Text] [Related]
2. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.
Li Y; Zhou H; Li F; Chan SW; Lin Z; Wei Z; Yang Z; Guo F; Lim CJ; Xing W; Shen Y; Hong W; Long J; Zhang M
Cell Res; 2015 Jul; 25(7):801-17. PubMed ID: 26045165
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into NF2/Merlin tumor suppressor function.
Cooper J; Giancotti FG
FEBS Lett; 2014 Aug; 588(16):2743-52. PubMed ID: 24726726
[TBL] [Abstract][Full Text] [Related]
4. The conformation change and tumor suppressor role of Merlin are both independent of Serine 518 phosphorylation.
Xing W; Li M; Zhang F; Ma X; Long J; Zhou H
Biochem Biophys Res Commun; 2017 Nov; 493(1):46-51. PubMed ID: 28919412
[TBL] [Abstract][Full Text] [Related]
5. Shedding light on Merlin's wizardry.
Okada T; You L; Giancotti FG
Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
[TBL] [Abstract][Full Text] [Related]
6. Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase.
Jin H; Sperka T; Herrlich P; Morrison H
Nature; 2006 Aug; 442(7102):576-9. PubMed ID: 16885985
[TBL] [Abstract][Full Text] [Related]
7. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
[TBL] [Abstract][Full Text] [Related]
8. Merlin, the NF2 gene product.
Pećina-Šlaus N
Pathol Oncol Res; 2013 Jul; 19(3):365-73. PubMed ID: 23666797
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Laulajainen M; Muranen T; Carpén O; Grönholm M
Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
[TBL] [Abstract][Full Text] [Related]
10. Merlin sumoylation is required for its tumor suppressor activity.
Qi Q; Liu X; Brat DJ; Ye K
Oncogene; 2014 Oct; 33(41):4893-903. PubMed ID: 24166499
[TBL] [Abstract][Full Text] [Related]
11. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
Sato T; Sekido Y
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
[TBL] [Abstract][Full Text] [Related]
12. NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation.
Wei Y; Yee PP; Liu Z; Zhang L; Guo H; Zheng H; Anderson B; Gulley M; Li W
EMBO Rep; 2020 Dec; 21(12):e50642. PubMed ID: 33058421
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer.
Mota MSV; Jackson WP; Bailey SK; Vayalil P; Landar A; Rostas JW; Mulekar MS; Samant RS; Shevde LA
Carcinogenesis; 2018 Sep; 39(9):1165-1175. PubMed ID: 29893810
[TBL] [Abstract][Full Text] [Related]
14. The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.
Cui Y; Groth S; Troutman S; Carlstedt A; Sperka T; Riecken LB; Kissil JL; Jin H; Morrison H
Oncogene; 2019 Sep; 38(36):6370-6381. PubMed ID: 31312020
[TBL] [Abstract][Full Text] [Related]
15. Monitoring Hippo Signaling Pathway Activity Using a Luciferase-Based Large Tumor Suppressor (LATS) Biosensor.
Pipchuk A; Yang X
Methods Mol Biol; 2022; 2525():155-169. PubMed ID: 35836066
[TBL] [Abstract][Full Text] [Related]
16. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.
Li W; You L; Cooper J; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Cell; 2010 Feb; 140(4):477-90. PubMed ID: 20178741
[TBL] [Abstract][Full Text] [Related]
17. A functional association between merlin and HEI10, a cell cycle regulator.
Grönholm M; Muranen T; Toby GG; Utermark T; Hanemann CO; Golemis EA; Carpén O
Oncogene; 2006 Jul; 25(32):4389-98. PubMed ID: 16532029
[TBL] [Abstract][Full Text] [Related]
18. Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1).
Li W; Giancotti FG
Cell Cycle; 2010 Nov; 9(22):4433-6. PubMed ID: 21084862
[TBL] [Abstract][Full Text] [Related]
19. Merlin cooperates with neurofibromin and Spred1 to suppress the Ras-Erk pathway.
Cui Y; Ma L; Schacke S; Yin JC; Hsueh YP; Jin H; Morrison H
Hum Mol Genet; 2021 Feb; 29(23):3793-3806. PubMed ID: 33331896
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
Horiguchi A; Zheng R; Shen R; Nanus DM
Prostate; 2008 Jun; 68(9):975-84. PubMed ID: 18361411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
